Moreover, inhibition of PI3K/Akt/mTOR and TLR4/MyD88/NF-κB signaling with targeted molecules can attenuate pathological mechanisms of asthma and play an important role in protecting airways against allergic response and inflammation pathology (63). This evidence concerns the gene TLR4 and asthma.